FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

716015005: Necitumumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3304441018 Necitumumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3304442013 Necitumumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1860411000195110 necitumumab it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
827371000172111 nécitumumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Necitumumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Necitumumab (substance) Is a Epidermal growth factor receptor inhibitor true Inferred relationship Some
Necitumumab (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Necitumumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Epidermal growth factor receptor inhibitor true Inferred relationship Some
Necitumumab (substance) Is a Enzyme inhibitor protein true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Necitumumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Necitumumab (substance) Inferred relationship Some 1
Product containing necitumumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Necitumumab (substance) Inferred relationship Some 1
Product containing only necitumumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Necitumumab (substance) Inferred relationship Some 1
Product containing only necitumumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Necitumumab (substance) Inferred relationship Some 1
Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Necitumumab (substance) Inferred relationship Some 1
Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Necitumumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start